Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

NCT01081574 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinoconjunctivitis
Chronic Urticaria

Interventions

DRUG: Bilastine

Sponsor

Faes Farma, S.A.